Abstract
This chapter deals with the marine biopharmaceuticals in the pipeline i.e.
year-wise number of approved marine drugs during the period 1969-2021 and their
clinical uses; approved and marketed drugs up to 2021; marine biota-derived drug
candidates under the different phases of clinical trials up to 2021; and marine
biotaderived clinical level compounds against SARS-CoV-2.
Keywords: Marine biopharmaceuticals in the pipeline, Year-wise approved marine drugs, Clinical uses of approved marine drugs, Marketed marine drugs up to 2021, and clinically tested marine compounds against SARS-CoV-2.
Related Journals
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Diabetes Reviews
Current Neurovascular Research
Current Respiratory Medicine Reviews
Current Pediatric Reviews
Infectious Disorders - Drug Targets
Current Stem Cell Research & Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets
Current Alzheimer Research
Current Aging Science
Related Books
Andrology: Current and Future Developments
Male Infertility: An Integrative Manual of Western and Chinese Medicine
Awake Thoracic Surgery
The Anatomical Foundations of Regional Anesthesia and Acute Pain Medicine Macroanatomy Microanatomy Sonoanatomy Functional anatomy
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents
Frontiers in Anti-infective Agents